Acetylcholinesterase inhibitors
1 paper3 findings
- 1 lab in 1 country
- Funders: Novo Nordisk and 1 more
- 3 of 3 findings with company ties
- Humans1
Associations
3Mortality
upin humans1
1 study
Mortality
upin humans1
Acetylcholinesterase inhibitors are associated with mortality in humans (53.3% vs. 21.7%).
Humanspost-initiation5 years
Scientific reports31 Aug 2026
Mobility disorders
upin humans1+55%
1 study
Mobility disorders
upin humans1+55%
Acetylcholinesterase inhibitors are associated with mobility disorders in humans (+ 55%).
Humanspre-initiation period8 years
Scientific reports31 Aug 2026
Modifiable risk factors
upin humans1
1 study
Modifiable risk factors
upin humans1
Acetylcholinesterase inhibitors are associated with modifiable risk factors in humans (81.9% vs. 76.2%).
Humanseight years pre-initiation
Scientific reports31 Aug 2026